BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36141691)

  • 1. The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan.
    Oortwijn W; Surgey G; Novakovic T; Baltussen R; Kosherbayeva L
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
    Baltussen R; Jansen M; Oortwijn W
    Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Gopinathan U
    Int J Health Policy Manag; 2023; 12():7541. PubMed ID: 37579471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Guzman J
    Int J Health Policy Manag; 2023; 12():7502. PubMed ID: 36086853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    DiStefano MJ
    Int J Health Policy Manag; 2023; 12():7480. PubMed ID: 37579447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran.
    Nouhi M; Baltussen R; Razavi SS; Bijlmakers L; Sahraian MA; Goudarzi Z; Farokhian P; Khedmati J; Jahangiri R; Olyaeemanesh A
    Int J Health Policy Manag; 2022 Dec; 11(11):2719-2726. PubMed ID: 35247943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment for sexual reproductive health and rights benefits package design in sub-Saharan Africa: A scoping review of evidence-informed deliberative processes.
    Simangolwa WM; Mbonigaba J; Govender K
    PLoS One; 2024; 19(6):e0306042. PubMed ID: 38935794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PROCESS OF PRIORITIZING TOPICS FOR HEALTH TECHNOLOGY ASSESSMENT IN KAZAKHSTAN.
    Kosherbayeva L; Hailey D; Kurakbaev K; Tabarov A; Kumar A; Gutzskaya G; Stepkina E
    Int J Technol Assess Health Care; 2016 Jan; 32(3):147-51. PubMed ID: 27502426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Bond K
    Int J Health Policy Manag; 2023; 12():7458. PubMed ID: 35988028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective.
    Kapiriri L; Baltussen R; Oortwijn W
    Int J Technol Assess Health Care; 2020; 36(1):29-33. PubMed ID: 31944173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
    Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
    BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT WORK IN A HOSPITAL IN KAZAKHSTAN.
    Kosherbayeva L; Hailey D; Kurakbaev K; Tsoy A; Zhuzzhanov O; Donbay A; Kumar A; Nadyrov K
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):78-80. PubMed ID: 26956362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deliberative processes in health technology assessment of medicines: the case of Spain.
    Pinilla-Dominguez P; Pinilla-Dominguez J
    Int J Technol Assess Health Care; 2023 Jul; 39(1):e50. PubMed ID: 37403252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness.
    Baltussen R; Jansen MP; Mikkelsen E; Tromp N; Hontelez J; Bijlmakers L; Van der Wilt GJ
    Int J Health Policy Manag; 2016 Nov; 5(11):615-618. PubMed ID: 27801355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage Comment on "Evidence-Informed Deliberative Processes for Health Benefits Package Design - Part II: A Practical Guide".
    Sajadi HS; Jama M; Majdzadeh R
    Int J Health Policy Manag; 2023; 12():7544. PubMed ID: 37579458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing an evidence-informed package of essential health services for Universal Health Coverage: lessons learnt and challenges to implementation in Liberia.
    Alwan A; Jallah W; Baltussen R; Carballo M; Gonyon E; Gudumac I; Haghparast-Bidgoli H; Jacobs G; Abou Jaoude GJ; Kateh FN; Logan G; Skordis J
    BMJ Glob Health; 2024 Jun; 9(6):. PubMed ID: 38925666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
    Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.